Table 2.
Sex hormone receptor | lncRNA | Cancer type | Relation with sex hormone receptor |
Role in cancer | Reference |
---|---|---|---|---|---|
ER | HOTAIR | Breast cancer | Inhibited by ER | Induce proliferation and tamoxifen resistance | [100] |
ERINA | Inhanced transactivation by ER | Induce proliferation and growth | [101] | ||
TROJAN, MIAT |
High in ER-positive breast cancer | Induce proliferation | [102,105] | ||
TMPO-AS1 | Stabilize ESR1 mRNA | Induce proliferation | [103] | ||
TCL6 | Low in ER-positive breast cancer | High probability in high expression patients | [104] | ||
H19 | Thyroid cancer | Promoted transcription by ERb | High probability in low expression patients | [106] | |
MALAT1 | Lung cancer | Increased expression by ERb | Induce vasculogenic mimicry formation and invasion | [107] | |
HOTAIR | Renal cancer | Inhanced by ER | Induce proliferation and invasion | [108] | |
LINC00263 | Lung cancer, Colorectal cancer, Renal cancer | Inhibited by ER | High expression in cancer tissue | [109] | |
AR | ARLNC1 | Prostate cancer | Induced by AR, stabilize AR transcription | Induce proliferation and growth | [113] |
LINC00844 | Regulate the transcriptional regulation of androgen-related genes | Induce proliferation and progression | [114] | ||
PRCAT38 | Increased through AR transactivation | Induce proliferation | [115] | ||
LINC00304 | Inhibit AR | Induce proliferation and cell cycle progression | [116] | ||
SARCC | Renal cancer | Inhibit activity of AR | Suppress tumor | [117] | |
HOTAIR | Promote activity of AR | Induce tumor angiogenesis | [118] | ||
SLNCR | Melanoma | Combined with AR | Induce proliferation | [119] | |
PART1 | Lung cancer, Colon cancer | Induced by androgen | Promote progression | [120,121] |
LncRNA, Long non-coding RNA; ER, estrogen receptor; ESR1, estrogen receptor 1 gene; AR, androgen receptor.